Corbiopharm SA
Corbiopharm reported total assets of 322,101 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026).
The score of Corbiopharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +11 % Total assets -7 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Corbiopharm's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 26,810 € | ||||
| Equity | 106,782 € | ||||
| Cash | 139,701 € | ||||
| EBITDA | 45,125 € | ||||
| Total assets | 322,101 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 28 Jul 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 27 Aug 2022
Corbiopharm's financial analysis
- Solvency33.2%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Corbiopharm
Corbiopharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0425.205.834
- VAT number
- BE0425205834
- Peppol
- Registered · 0208:0425205834 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 23 Jan 1984
- Registered office
- 6838 Bouillon
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Corbiopharm (SA) has been based in Bouillon since 1984, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 26,810 € and equity of 106,782 €; its revenue is not published. Its solvency stands at 33.2%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Corbiopharm
Companies in the same business, of comparable size and area, outside its group.
- Hubert Services Management Retail sale of pharmaceutical products Estinnes · balance sheet 65,144 €
- Osteoserv Retail sale of pharmaceutical products Kinrooi · balance sheet 442,674 €
- JONCKHEERE Consultance Retail sale of pharmaceutical products Stavelot · balance sheet 460,876 €
- Apotheek Donk Retail sale of pharmaceutical products Herk-de-Stad · balance sheet 468,888 €
- Isecophar Other human health activities n.e.c. Genappe · balance sheet 292,254 €
- Tannhauser Pharaescos Retail sale of pharmaceutical products Koekelberg · balance sheet 292,153 €
- Pharmacie du Parc Astrid Retail sale of pharmaceutical products Anderlecht · balance sheet 342,276 €
- Mieke de Geeter Retail sale of pharmaceutical products Kortrijk · balance sheet 58,191 €
Frequently asked questions about Corbiopharm
What is the revenue of Corbiopharm?
Corbiopharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Corbiopharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0425205834 for Corbiopharm, if the company is VAT-registered. Its company number (CBE) is 0425.205.834.
Where is the registered office of Corbiopharm?
According to the CBE register, the registered office of Corbiopharm is in 6838 Bouillon.
What is the equity of Corbiopharm?
At the close of the 2025 financial year, the equity of Corbiopharm amounts to 106,782 €, a solvency of 33.2% of total assets.
Who manages Corbiopharm?
The register lists 4 active mandates at Corbiopharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Corbiopharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →